Intec Pharma Ltd. (NASDAQ:NTEC) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation of the two firms.
Valuation and Earnings
Table 1 shows top-line revenue, earnings per share and valuation of the two companies.
Table 2 shows us the return on equity, return on assets and net margins of both businesses.
Recommendations and Ratings for Intec Pharma Ltd. and Infinity Pharmaceuticals Inc. can be find in next table.
Meanwhile, Infinity Pharmaceuticals Inc.’s average target price is $3, while its potential upside is 108.33%.
Insider and Institutional Ownership
The shares of both Intec Pharma Ltd. and Infinity Pharmaceuticals Inc. are owned by institutional investors at 39.64% and 54.9% respectively. 11.81% are Intec Pharma Ltd.’s share owned by insiders.